Skip to main content

Table 1 Patient characteristics

From: Data for drugs available through low-cost prescription drug programs are available through pharmacy benefit manager and claims data

Chains

Number of Patients

Age of dispensing

Female

White

(Mean±SD)

Chain1†

424

63.9

± 12.0

50.70%

83.20%

Chain2

489

61.2

± 13.0

43.90%

87.50%

Chain3

693

66.4

± 10.4

51.50%

81.70%

Chain4†

727

60.7

± 13.1

45.20%

91.20%

Chain5†

810

53.5

± 12.3

52.30%

84.20%

Chain6‡

966

57.3

± 12.6

45.60%

83.60%

Chain7

1,708

60.8

± 11.0

40.10%

89.60%

Chain8

2,892

60.8

± 10.2

40.80%

91.80%

Chain9

3,461

64.0

± 11.0

43.10%

87.80%

Chain10†

3,932

59.1

± 12.8

51.00%

87.70%

Chain11†

5,623

57.6

± 12.3

50.80%

82.40%

Chain12

7,971

58.2

± 12.8

51.70%

75.10%

Chain13

9,882

66.6

± 10.6

43.10%

85.10%

Chain14†

16,788

59.1

± 12.9

49.00%

79.00%

MEPS

13.7million

60.7

± 12.8

44.2%

66.8%

  1. † Chain with a LCPP.
  2. ‡ Chain with LCPP for Chlorpropamide only.